Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 49 studies | 46% ± 19% | |
macrophage | 36 studies | 38% ± 18% | |
fibroblast | 26 studies | 27% ± 9% | |
pericyte | 25 studies | 31% ± 14% | |
classical monocyte | 23 studies | 35% ± 13% | |
non-classical monocyte | 23 studies | 34% ± 10% | |
conventional dendritic cell | 22 studies | 34% ± 12% | |
basal cell | 22 studies | 46% ± 15% | |
dendritic cell | 20 studies | 35% ± 14% | |
monocyte | 18 studies | 37% ± 17% | |
smooth muscle cell | 18 studies | 30% ± 10% | |
epithelial cell | 16 studies | 35% ± 19% | |
endothelial cell of lymphatic vessel | 15 studies | 37% ± 14% | |
capillary endothelial cell | 15 studies | 48% ± 14% | |
endothelial cell of vascular tree | 15 studies | 60% ± 24% | |
vein endothelial cell | 14 studies | 54% ± 17% | |
endothelial cell of artery | 12 studies | 42% ± 11% | |
myeloid cell | 12 studies | 36% ± 17% | |
type II pneumocyte | 10 studies | 35% ± 12% | |
neutrophil | 10 studies | 32% ± 9% | |
secretory cell | 10 studies | 32% ± 14% | |
myofibroblast cell | 10 studies | 34% ± 14% | |
ciliated cell | 10 studies | 36% ± 19% | |
microglial cell | 10 studies | 32% ± 10% | |
connective tissue cell | 9 studies | 27% ± 11% | |
goblet cell | 9 studies | 36% ± 14% | |
alveolar macrophage | 8 studies | 32% ± 9% | |
club cell | 8 studies | 29% ± 15% | |
mononuclear phagocyte | 7 studies | 38% ± 13% | |
ionocyte | 6 studies | 32% ± 7% | |
intestinal crypt stem cell | 6 studies | 41% ± 19% | |
leukocyte | 6 studies | 26% ± 8% | |
respiratory goblet cell | 5 studies | 32% ± 15% | |
keratinocyte | 5 studies | 46% ± 15% | |
glomerular endothelial cell | 4 studies | 72% ± 4% | |
transit amplifying cell | 4 studies | 32% ± 5% | |
abnormal cell | 4 studies | 28% ± 6% | |
hematopoietic stem cell | 4 studies | 19% ± 5% | |
pro-B cell | 4 studies | 34% ± 9% | |
enterocyte | 4 studies | 23% ± 3% | |
inflammatory macrophage | 4 studies | 29% ± 10% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 28% ± 6% | |
mast cell | 3 studies | 24% ± 6% | |
type I pneumocyte | 3 studies | 32% ± 6% | |
hillock cell | 3 studies | 26% ± 2% | |
mesothelial cell | 3 studies | 30% ± 14% | |
tissue-resident macrophage | 3 studies | 36% ± 6% | |
intermediate monocyte | 3 studies | 52% ± 0% | |
endothelial cell of sinusoid | 3 studies | 42% ± 13% | |
hepatocyte | 3 studies | 54% ± 28% | |
monocyte-derived dendritic cell | 3 studies | 39% ± 10% | |
muscle cell | 3 studies | 36% ± 6% | |
glutamatergic neuron | 3 studies | 42% ± 13% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 40% ± 17% | |
enteroendocrine cell | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 32% ± 13% | |
intestine | 8 studies | 25% ± 8% | |
brain | 5 studies | 27% ± 8% | |
uterus | 4 studies | 36% ± 5% | |
liver | 4 studies | 27% ± 9% | |
prostate | 4 studies | 40% ± 12% | |
skin | 4 studies | 33% ± 5% | |
peripheral blood | 3 studies | 29% ± 11% | |
breast | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11473.29 | 1439 / 1445 | 100% | 147.93 | 183 / 183 |
intestine | 99% | 13771.79 | 960 / 966 | 100% | 312.34 | 525 / 527 |
lung | 100% | 28597.38 | 578 / 578 | 98% | 126.43 | 1136 / 1155 |
bladder | 100% | 18462.43 | 21 / 21 | 97% | 185.92 | 490 / 504 |
uterus | 100% | 12440.26 | 170 / 170 | 96% | 189.72 | 439 / 459 |
thymus | 100% | 11098.56 | 651 / 653 | 95% | 59.63 | 574 / 605 |
liver | 98% | 18653.46 | 222 / 226 | 95% | 88.16 | 385 / 406 |
stomach | 90% | 9715.17 | 324 / 359 | 99% | 245.50 | 283 / 286 |
kidney | 100% | 9816.27 | 89 / 89 | 88% | 89.62 | 791 / 901 |
prostate | 99% | 14382.11 | 242 / 245 | 84% | 61.24 | 423 / 502 |
breast | 100% | 14444.54 | 458 / 459 | 68% | 32.78 | 760 / 1118 |
adrenal gland | 82% | 4161.28 | 211 / 258 | 67% | 43.83 | 153 / 230 |
ovary | 98% | 9899.18 | 176 / 180 | 48% | 18.78 | 205 / 430 |
brain | 60% | 3571.98 | 1584 / 2642 | 85% | 39.29 | 597 / 705 |
skin | 86% | 25586.01 | 1555 / 1809 | 38% | 16.96 | 180 / 472 |
pancreas | 27% | 1289.55 | 90 / 328 | 96% | 110.63 | 171 / 178 |
spleen | 100% | 30009.60 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.54 | 1 / 1 |
adipose | 100% | 16617.40 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 15006.30 | 1327 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 164.58 | 44 / 45 |
muscle | 96% | 14269.35 | 774 / 803 | 0% | 0 | 0 / 0 |
heart | 87% | 6414.33 | 747 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 39.41 | 63 / 80 |
peripheral blood | 67% | 6340.05 | 627 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 9.25 | 8 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001712 | Biological process | ectodermal cell fate commitment |
GO_0007498 | Biological process | mesoderm development |
GO_0090009 | Biological process | primitive streak formation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0030154 | Biological process | cell differentiation |
GO_0001501 | Biological process | skeletal system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ETS2 |
Protein name | ETS proto-oncogene 2, transcription factor Protein C-ets-2 |
Synonyms | |
Description | FUNCTION: Transcription factor activating transcription. Binds specifically the DNA GGAA/T core motif (Ets-binding site or EBS) in gene promoters and stimulates transcription. . |
Accessions | ENST00000667466.1 ENST00000456966.1 ENST00000360214.8 A0A590UJR2 ENST00000665212.1 ENST00000653642.1 A0A590UJP9 C9JAG2 ENST00000360938.8 P15036 ENST00000662305.1 ENST00000432278.5 A0A0C4DG47 ENST00000666778.1 |